| Investor | Value | Of portfolio | Shares | Change | Quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | $7.0M | 0.01% | 325.38K | −4.5% | Q2 2026 |
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a NRC trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 22, 2026 | Lockhart Stephen HDirector | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Jun 22, 2026 | Wheeler Penny AnnDirector | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Jun 22, 2026 | Bhandari ParulDirector | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Jun 22, 2026 | Nunnelly John NDirector | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Jun 22, 2026 | Berwick Donald M M.D.Director | Stock Award(Grant) at price 0.00 per share. | 7.7K | — |
| Mar 11, 2026 | Rau Jason RussellOfficer | Stock Award(Grant) at price 0.00 per share. | 60K | — |
| Feb 16, 2026 | Harrison Shane RChief Financial Officer | Purchase at price 12.27 per share. | 8K | $98.16K |
| Jan 4, 2026 | Burik DavidOfficer | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| Jan 4, 2026 | Hays Michael DChairman of the Board | Conversion of Exercise of derivative security at price 15.23 per share. | 9.1K | $139.28K |
| Dec 14, 2025 | Hrdy HelenChief Operating Officer | Conversion of Exercise of derivative security at price 15.23 per share. | 12.3K | $188.03K |
| Sep 28, 2025 | Harrison Shane RChief Financial Officer | Stock Award(Grant) at price 0.00 per share. | 172K | — |
| Jul 30, 2025 | Freeman Jordan NicoleOfficer | Purchase at price 12.97 per share. | 771 | $10.00K |
| May 29, 2025 | Green Trent S.Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | 500K | — |
| May 11, 2025 | Beans Patrick EBeneficial Owner of more than 10% of a Class of Security | Purchase at price 13.59 per share. | 2.5K | $33.97K |
| Apr 6, 2025 | Hrdy HelenChief Operating Officer | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| Apr 6, 2025 | Monnich AndrewOfficer | Stock Award(Grant) at price 0.00 per share. | 100K | — |
| Jan 1, 2025 | Hays Michael DChief Executive Officer | Conversion of Exercise of derivative security at price 13.17 per share. | 10K | $131.88K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 8.4 | -34.1 | 26.6 | -3.1 | 18.7 | 10.4 | -9.6 | 7.3 | 1.2 | -4.1 | +8.3% | ||
| 2025 | -5.5 | -12.5 | -12.3 | -11.3 | 18.9 | 24.4 | -25.6 | 17.5 | -13.0 | 4.5 | 27.2 | 10.5 | +6.4% |
| 2024 | -0.4 | 2.3 | -1.8 | -13.5 | -18.0 | -18.3 | 11.1 | -10.6 | 0.3 | -20.7 | 8.4 | -10.3 | −55.4% |
| 2023 | 24.5 | -2.7 | -3.7 | 0.0 | 3.1 | -3.1 | -1.4 | -2.6 | 6.1 | -4.8 | -2.0 | -4.5 | +6.1% |
| 2022 | 0.2 | -4.4 | -0.3 | -13.5 | 4.6 | 6.7 | -1.0 | -10.0 | 16.7 | 2.3 | -4.9 | -3.7 | −10.2% |
| 2021 | 6.0 | 14.1 | -9.4 | 9.5 | -6.8 | -4.0 | 15.0 | 2.3 | -21.9 | 2.7 | -7.5 | 3.7 | −2.9% |
| 2020 | 2.6 | -18.7 | -17.3 | 13.4 | 9.9 | 2.6 | -1.8 | -2.1 | -12.1 | 5.3 | -0.9 | -16.7 | −35.2% |
| 2019 | 4.8 | -2.6 | -0.8 | 2.5 | 28.8 | 12.9 | 17.1 | -5.0 | -9.8 | -0.6 | 12.3 | 2.2 | +72.9% |
| 2018 | 0.9 | -24.8 | 3.4 | 11.8 | 5.4 | 8.6 | 1.5 | 3.2 | -1.4 | -1.4 | 4.8 | -4.3 | +2.3% |
| 2017 | -8.2 | 6.9 | 5.6 | 25.9 | -3.2 | 12.1 | 9.3 | 9.9 | 16.7 | -0.4 | -9.6 | 9.9 | +96.3% |
| 2016 | -5.9 | -0.8 | 3.9 | -7.5 | -4.8 | 0.0 | 9.6 | 5.4 | 2.9 | -5.8 | 4.2 | 18.8 | +18.5% |
| 2015 | -1.0 | 0.4 | 3.6 | 0.1 | -3.1 | 1.6 | 4.2 | -13.9 | -6.4 | 28.4 | 0.8 | 3.8 | +14.7% |
| 2014 | -20.3 | 16.7 | -5.2 | -5.0 | -4.5 | -7.0 | -5.6 | 5.9 | -7.0 | 22.1 | -10.9 | -1.2 | −25.7% |
| 2013 | 10.1 | -0.1 | -8.8 | 14.9 | -6.9 | 4.4 | 2.8 | +15.1% |
Buy / hold / sell counts
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.